Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
MITF tumor syndrome
Other Resources UpToDate PubMed

MITF tumor syndrome

Contributors: Catherine Laferté, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

MITF (microphthalmia-associated transcription factor) tumor syndrome is a genetic syndrome that predisposes to the development of melanoma and renal cell cancer. Affected individuals have been found to have a particular missense mutation in the MITF gene (318 glu-to-lys) that has been reported to increase the risk of melanoma and renal cell cancer by up to 5 times that of the unaffected population. MITF is a transcription factor that is involved in cell cycle regulation; the mutation alters the transcription of MITF target genes.

Affected kindreds have been reported to have lighter skin phototypes, non-blue eye color, higher nevus count (mainly reticular pattern under dermoscopy), and onset of melanoma in those younger than 40 years. Some cohorts have demonstrated predominance of nevi greater than 5 mm in diameter, atypical nevi, multiple primary melanomas, and amelanotic melanomas. While some studies found an association with darker hair colors, others did not.

Codes

ICD10CM:
Z15.09 – Genetic susceptibility to other malignant neoplasm

SNOMEDCT:
770896003 – MITF-related melanoma and renal cell carcinoma predisposition syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:08/30/2021
Last Updated:01/19/2022
Copyright © 2024 VisualDx®. All rights reserved.
MITF tumor syndrome
Print  
A medical illustration showing key findings of MITF tumor syndrome
Copyright © 2024 VisualDx®. All rights reserved.